Copperleaf Capital LLC Sells 833 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Copperleaf Capital LLC reduced its stake in UnitedHealth Group by 39.4%, owning 1,281 shares post-sale, valued at approximately $671,000.
• UnitedHealth Group reported disappointing quarterly earnings of $4.08 EPS, falling short of analysts' expectations of $4.45, with a revenue of $111.62 billion.
• The company announced a quarterly dividend of $2.21 per share, representing a 2.9% yield based on its current share price.

Copperleaf Capital LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 39.4% in the first quarter, according to its most recent filing with the SEC. The fund owned 1,281 shares of the healthcare conglomerate's stock after selling 833 shares during the period. Copperleaf Capital LLC's holdings in UnitedHealth Group were worth $671,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in the business. Banque Transatlantique SA raised its position in UnitedHealth Group by 16.6% in the 1st quarter. Banque Transatlantique SA now owns 2,905 shares of the healthcare conglomerate's stock worth $1,406,000 after purchasing an additional 414 shares during the period. AQR Capital Management LLC raised its position in UnitedHealth Group by 251.5% in the 1st quarter. AQR Capital Management LLC now owns 784,689 shares of the healthcare conglomerate's stock worth $410,981,000 after purchasing an additional 561,451 shares during the period. Alyeska Investment Group L.P. raised its position in UnitedHealth Group by 21.1% in the 1st quarter. Alyeska Investment Group L.P. now owns 70,000 shares of the healthcare conglomerate's stock worth $36,662,000 after purchasing an additional 12,198 shares during the period. Appaloosa LP increased its position in shares of UnitedHealth Group by 0.3% in the first quarter. Appaloosa LP now owns 175,000 shares of the healthcare conglomerate's stock valued at $91,656,000 after acquiring an additional 500 shares during the period. Finally, Aprio Wealth Management LLC raised its stake in shares of UnitedHealth Group by 10.0% during the first quarter. Aprio Wealth Management LLC now owns 1,471 shares of the healthcare conglomerate's stock valued at $770,000 after acquiring an additional 134 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $307.27 on Thursday. The stock has a market cap of $278.29 billion, a PE ratio of 13.31, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The firm's 50-day simple moving average is $288.51 and its two-hundred day simple moving average is $377.17.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the previous year, the company earned $6.80 EPS. The company's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. TD Securities reaffirmed a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Finally, Mizuho decreased their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. Fifteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $353.00.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.